“In silico studies of quinazolinone analogues to distinguish their hypothetical binding mode using the X-ray crystal structure human carbon anhydrase II (HCAII) enzyme complex with sugar sulfamate for anticonvulsant activity” (2023) International Journal of Pharmaceutical Sciences and Drug Research, 15(5), pp. 675–679. doi:10.25004/IJPSDR.2023.150516.